Evidence map›Paper›PMID 31770287›Full record

Trial reportMedicine2019

Propofol vs desflurane on the cytokine, matrix metalloproteinase-9, and heme oxygenase-1 response during living donor liver transplantation: A pilot study.

Zhi-Fu Wu, Wei-Lin Lin, Meei-Shyuan Lee, Nan-Kai Hung, Yuan-Shiou Huang, Teng-Wei Chen, Chueng-He Lu

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06457958 (The Effect of Sevoflurane and Desflurane Anesthetic Agents Used in Elective Cholecystectomy Surgery on Heme Oxygenase-1 mRNA Expression and Heme Oxygenase-1 Protein Levels), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06457958 phase4withdrawnnot on this mapstarted 2025, after this paper: background citation

The Effect of Sevoflurane and Desflurane Anesthetic Agents Used in Elective Cholecystectomy Surgery on Heme Oxygenase-1 mRNA Expression and Heme Oxygenase-1 Protein Levels: A Comparative Prospective Study

TypeinterventionalSponsorKocaeli City HospitalRan2025 to 2025Enrolled0ConditionsCholecystitis, ChronicArmsSevoflurane Group, Desflurane Group
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Zhi-Fu WuDepartment of Anesthesiology, Chi Mei Medical Center, Tainan.
Wei-Lin LinDepartment of Anesthesiology, National Defense Medical Center and Tri-Service General Hospital.
Meei-Shyuan LeeSchool of Public Health, National Defense Medical Center.
Nan-Kai HungDepartment of Anesthesiology, National Defense Medical Center and Tri-Service General Hospital.
Yuan-Shiou HuangDepartment of Anesthesiology, National Defense Medical Center and Tri-Service General Hospital.
Teng-Wei ChenDivision of General Surgery, National Defense Medical Center and Tri-Service General Hospital, Taipei, Taiwan.
Chueng-He LuDepartment of Anesthesiology, National Defense Medical Center and Tri-Service General Hospital.
Matrix Research (United States) · USTri-Service General Hospital · TWNational Defense Medical Center · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe investigated the effects of propofol vs desflurane on ischemia and reperfusion injury (IRI)-induced inflammatory responses, especially in matrix metalloproteinase-9 (MMP-9) downregulation and heme oxygenase-1 (HO-1) upregulation, which may result in different clinical outcomes in liver transplant recipients.

methodsFifty liver transplant recipients were randomized to receive propofol-based total intravenous anesthesia (TIVA group, n = 25) or desflurane anesthesia (DES group, n = 25). We then measured the following: perioperative serum cytokine concentrations (interleukin 1 receptor antagonist [IL-1RA], IL-6, IL-8, and IL-10); MMP-9 and HO-1 mRNA expression levels at predefined intervals. Further, postoperative outcomes were compared between the 2 groups.

resultsThe TIVA group showed a significant HO-1 level increase following the anhepatic phase and a significant MMP-9 reduction after reperfusion, in addition to a significant increase in IL-10 levels after the anhepatic phase and IL-1RA levels after reperfusion. Compared to DES patients, TIVA patients showed a faster return of the international normalized ratio to normal values, lower plasma alanine aminotransferase concentrations 24 hours after transplantation, and fewer patients developing acute lung injury. Moreover, compared with DES patients, TIVA patients showed a significant reduction in serum blood lactate levels. However, there were no differences in postoperative outcomes between the two groups.

conclusionPropofol-based TIVA attenuated inflammatory response (elevated IL-1RA and IL-10 levels), downregulated MMP-9 response, and increased HO-1 expression with improved recovery of graft function and better microcirculation compared with desflurane anesthesia in liver transplant recipients.

Indexed as

DesfluraneLiver TransplantationPropofolReperfusion InjuryAdultAnesthetics, InhalationAnesthetics, IntravenousFemaleHeme Oxygenase-1HumansInterleukin-10Interleukin 1 Receptor Antagonist ProteinMaleMatrix Metalloproteinase 9Postoperative PeriodTransplantation ImmunologyAnesthetics, InhalationAnesthetics, IntravenousDesfluraneHeme Oxygenase-1Interleukin-10Interleukin 1 Receptor Antagonist ProteinMatrix Metalloproteinase 9Propofol

Identifiers

PMID31770287
PMCPMC6890360
OpenAlexW2991062035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.